Barer SOL J
SEC-identified person · CIK 1247015 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Teva Pharmaceutical Industries LTD TEVA | Director | filed 2018–2026 |
| Neximmune, Inc. NEXI | Director | filed 2021–2023 |
| Contrafect Corp CRFX | Director | filed 2014–2022 |
| Cerecor Inc. CERC | Director | filed 2020–2021 |
| Medgenics, INC. MDGN | Director | filed 2012–2020 |
| PDS Biotechnology Corp PDSB | Director | filed 2015–2019 |
| Inspiremd, Inc. SAGU | Director | filed 2011–2016 |
| Aegerion Pharmaceuticals, Inc. AEGR | Director | filed 2011–2016 |
| Amicus Therapeutics, INC. [FOLD} | Director | filed 2009–2016 |
| Stratus Media Group, Inc SMDID | Director · Chairman of the Board | filed 2013–2014 |
| Celgene Corp /DE/ CELG | Director · Executive Chairman | filed 2006–2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.